NPI: 1548466220 · KNOXVILLE, TN 37918 · Primary Care Clinic/Center · NPI assigned 06/21/2007
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| Parent Organization | EAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER INC. |
| NPI Enumeration Date | 06/21/2007 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,450 | $201K |
| 2019 | 3,816 | $82K |
| 2020 | 4,923 | $119K |
| 2021 | 5,829 | $174K |
| 2022 | 7,084 | $235K |
| 2023 | 7,865 | $269K |
| 2024 | 11,471 | $339K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,007 | 6,609 | $546K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,558 | 1,348 | $154K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,692 | 1,419 | $148K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,314 | 1,153 | $134K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3,080 | 2,747 | $133K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 934 | 837 | $98K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,025 | 3,136 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,403 | 4,598 | $27K |
| 80061 | Lipid panel | 2,323 | 2,016 | $19K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 122 | 118 | $14K |
| 99177 | 2,560 | 2,266 | $13K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 293 | 261 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 664 | 603 | $11K |
| 96161 | 1,045 | 878 | $7K | |
| 92551 | 522 | 479 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 130 | 115 | $5K |
| 96127 | 850 | 767 | $5K | |
| 3008F | 3,016 | 2,673 | $5K | |
| 36416 | 5,120 | 4,307 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 313 | 274 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 212 | 183 | $3K |
| 81003 | 2,164 | 1,819 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 218 | 192 | $2K |
| 99381 | 12 | 12 | $2K | |
| 86738 | 180 | 149 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17 | 16 | $872.27 |
| 92567 | 58 | 47 | $840.43 | |
| 83655 | 75 | 54 | $578.63 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 16 | 13 | $361.50 |
| 90677 | 258 | 237 | $298.04 | |
| 87807 | 31 | 29 | $232.38 | |
| 36415 | Collection of venous blood by venipuncture | 296 | 265 | $185.02 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 55 | 50 | $93.84 |
| 90686 | 837 | 717 | $85.76 | |
| 90656 | 137 | 133 | $44.70 | |
| 90670 | 544 | 484 | $0.00 | |
| 90633 | 26 | 24 | $0.00 | |
| 90685 | 29 | 23 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 55 | 50 | $0.00 |
| 90680 | 438 | 409 | $0.00 | |
| 90723 | 449 | 419 | $0.00 | |
| 90647 | 360 | 319 | $0.00 |